Sector News

Croda completes international acquisitions

January 15, 2018
Chemical Value Chain

Listed speciality chemicals giant Croda International, which supplies products for some of the world’s biggest brands, has completed two international acquisitions.

Nautilus Biosciences Canada is a technology-rich marine biotechnology company based in Charlottetown, Canada.

The two companies have worked together for the past six years developing specific applications for skin care and hair care, as well as crop care. Croda intends to establish Nautilus as a Croda centre of innovation for Marine Biotechnology at its existing base at the University of Prince Edward Island.

Goole-headquartered Croda has also completed the acquisition of IonPhasE, an innovative technology supplier of static electricity protection products, headquartered in Tampere, Finland.

Steve Foots, chief executive of Croda, said: “These acquisitions are very much aligned to our strategy of investing in disruptive technologies, clever people and rich intellectual property. With Nautilus as part of the Croda group, we further expand our expertise in biotechnology; the Nautilus team that will join us have extensive knowledge and expertise in marine biotechnology, also known as ‘blue biotechnology’.

“The experience and knowledge of the IonPhasE management team, coupled with our innovation strength, global sales reach and complementary technologies, will allow us to better meet the needs of our customers within our Smart Materials business within the Performance Technologies sector.”

Croda has now completed four acquisitions and co-investments completed in the last 12 months. The latest deals follow the purchase of Swedish research enterprise Enza Biotech in July 2017 and an investment in Cutitronics, a UK technology-based innovator of personalised, adaptive skin care.

By Stephen Farrell

Source: Insider Media

comments closed

Related News

October 2, 2022

Trinseo announces potential closure of Boehlen, Germany Styrene Plant

Chemical Value Chain

Trinseo (NYSE: TSE), a specialty material solutions provider, announced it has initiated an information and consultation process with the Works Council of Trinseo Deutschland GmbH regarding the potential closure of its styrene monomer production site in Boehlen, Germany.

October 2, 2022

Celeste Mastin appointed H.B. Fuller President and CEO, succeeding Jim Owens upon his retirement

Chemical Value Chain

H.B. Fuller Company announced that Celeste Mastin, Executive Vice President and Chief Operating Officer, will succeed Jim Owens as H.B. Fuller’s President and Chief Executive Officer, effective December 4, 2022. Upon assuming the role, Mastin will also join the Company’s Board of Directors, replacing Owens, who will be retiring.

October 2, 2022

LyondellBasell realigns executive team, forms circular and low-carbon solutions business

Chemical Value Chain

New LyondellBasell CEO Peter Vanacker, who joined the company from Neste in May, today named his senior executive team and outlined organizational changes, including creation of a circular and low-carbon solutions business. All changes will be effective 1 October.